Pfizer

Latest Stories

The anti-viral drug Paxlovid is displayed in New York, Monday, Aug. 1, 2022. Pfizer received full approval for the COVID-19 medication on Thursday, May 25, 2023, winning the U.S. Food and Drug Administration's full endorsement for a drug that has been the go-to treatment against the virus for more than two years. (AP Photo/Stephanie Nano, File)

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

By Matthew Perrone - Associated Press

Trump versus DeSantis More Fun than a Barrel of Ross Perots Illustration by Greg Groesch/The Washington Times

Handicapping Trump versus DeSantis faceoff

By Peter Navarro

This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colorized blue, and anti-RSV F protein/gold antibodies, colorized yellow, shedding from the surface of human lung cells. Advisers to the Food and Drug Administration on Thursday, May 18, 2023 debated a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy. (National Institute of Allergy and Infectious Diseases, NIH via AP)

FDA advisers back RSV vaccine for pregnant women that protects their newborns

By Lauran Neergaard - Associated Press

A nurse administers a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. U.S. regulators on Tuesday, April 18, 2023, cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else.(AP Photo/Rogelio V. Solis)

Extra spring COVID-19 booster cleared for certain Americans

By Lauran Neergaard - Associated Press

A patient prepares to take the first of two pills for a medication abortion during a visit to a clinic in Kansas City, Kan., on Wednesday, Oct. 12, 2022. Some abortion clinics are fielding lots of calls from patients since a Friday, April 7, 2023 court ruling threatened the availability of a main drug used in medication abortion, mifepristone. Patients are concerned about whether they can still get the care they need. (AP Photo/Charlie Riedel) **FILE**

Drugmakers urge appeals court to stay Texas ruling on abortion pill

By Tom Howell Jr. - The Washington Times

A Jackson-Hinds Comprehensive Health Center nurse loads a syringe with a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. Moderna recently announced early evidence that its updated booster induced BQ.1.1-neutralizing antibodies. (AP Photo/Rogelio V. Solis)

Vaccine makers pick Senate fight over soaring prices; fall boosters cost up to $130

By Tom Howell Jr. and Haris Alic - The Washington Times

A man walks by Pfizer headquarters, Friday, Feb. 5, 2021 in New York. Pfizer is spending more than $11 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own. The New York drugmaker said Tuesday, May 10, 2022, it will pay $148.50 in cash for each share of Biohaven, which makes Nurtec ODT for treating and preventing migraines and has another nasal spray under development. (AP Photo/Mark Lennihan, File)

Pfizer ‘recalls’ 4.2 million boxes of Nurtec migraine medicine due to lack of childproofing

By Brad Matthews - The Washington Times

A health worker administers a dose of COVID-19 vaccine during a vaccination clinic in Reading, Pa. on Sept. 14, 2021. On Friday, March 10, 2023, The Associated Press reported on stories circulating online incorrectly claiming the U.S. military has recorded a 500% increase in new HIV infections since COVID-19 vaccines were introduced. (AP Photo/Matt Rourke, File)

Congress’ pandemic probe asks whether Biden officials cut corners to fast-track vaccine approvals

By Joseph Clark - The Washington Times

President Joe Biden talks with reporters on the South Lawn of the White House in Washington, Monday, Jan. 30, 2023, after returning from an event in Baltimore on infrastructure. (AP Photo/Susan Walsh)

Biden to end COVID-19 emergencies on May 11

By Zeke Miller and Amanda Seitz - Associated Press

Family members of the deceased line up for the cremation procedures at a funeral home in Shanghai, China on Jan. 4, 2023. China on Saturday, Jan. 14, reported nearly 60,000 deaths in people who had COVID-19 since early December following complaints the government was failing to release data about the status of the pandemic. (Chinatopix Via AP)

Chinese scramble to find leading COVID treatment after national pivot on virus

By Tom Howell Jr. - The Washington Times

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

By Joseph Clark - The Washington Times

Republican Florida Governor Ron DeSantis speaks during a campaign rally, Nov. 7, 2022, in Hialeah, Fla. The long-rumored memoir by Gov. DeSantis is coming out next year. The HarperCollins imprint Broadside will release “The Courage to Be Free: Florida’s Blueprint for America’s Revival” on Feb. 28. The announcement, Wednesday, Nov. 30, 2022 comes in the wake of DeSantis’ decisive reelection victory and will likely add to speculation that he plans a run for the Republican presidential nomination in 2024. (AP Photo/Lynne Sladky)

DeSantis announces grand jury probe of COVID-19 shots

By Susan Ferrechio - The Washington Times

Illustration on Congrsssional price controls on prescription drugs and the resulting unfair benefits to bigger biotech companies by Alexander Hunter/The Washington Times

Price controls in the Inflation Reduction Act will drive small biotechs out of business

By Karen Kerrigan

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. The U.S. on Thursday, Dec. 8, 2022 open doses of the updated COVID-19 vaccines for most children younger than age 5. The Food and Drug Administration's decision aims to better protect the littlest kids from severe COVID-19 at a time when children’s hospitals already are packed with tots suffering a variety of other respiratory illnesses, too. (AP Photo/Ted S. Warren, file)

FDA clears updated COVID-19 vaccines for kids under age 5

By Lauran Neergaard - Associated Press

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5. The youngest tots already are supposed to get three extra-small doses of the original vaccine as their primary series. Pfizer and its partner BioNTech said Monday, Dec. 5, 2022 that if the Food and Drug Administration agrees, the updated vaccine would be used for the third shot. The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. (AP Photo/Ted S. Warren, file)

Pfizer asks FDA to clear updated COVID shot for kids under 5

By Lauran Neergaard - Associated Press

A COVID vaccine, left, is readied as a flu vaccine sits nearby at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif. (AP Photo/Mark J. Terrill)

Pfizer, Moderna work on a single shot for flu and COVID-19

By Tom Howell Jr. - The Washington Times

Pfizer study says updated COVID boosters rev up protection

By Lauran Neergaard - Associated Press

A man walks by Pfizer headquarters in New York on Friday, Feb. 5, 2021. (AP Photo/Mark Lennihan) **FILE**

Pfizer sued for excluding White, Asian candidates from fellowship

By Sean Salai - The Washington Times

Pfizer begins late-stage human study on an mRNA flu shot

By Tom Howell Jr. - The Washington Times

This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (Pfizer via AP)

Should you get a new COVID booster? If so, when?

By Lauran Neergaard - Associated Press